Anti-TTC9B functional antibody

Anti-TTC9B functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to TTC9B/TTC9B products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE1351-Ab-1/ GM-Tg-hg-SE1351-Ab-2Anti-Human TTC9B monoclonal antibodyHuman
GM-Tg-rg-SE1351-Ab-1/ GM-Tg-rg-SE1351-Ab-2Anti-Rat TTC9B monoclonal antibodyRat
GM-Tg-mg-SE1351-Ab-1/ GM-Tg-mg-SE1351-Ab-2Anti-Mouse TTC9B monoclonal antibodyMouse
GM-Tg-cynog-SE1351-Ab-1/ GM-Tg-cynog-SE1351-Ab-2Anti-Cynomolgus/ Rhesus macaque TTC9B monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE1351-Ab-1/ GM-Tg-felg-SE1351-Ab-2Anti-Feline TTC9B monoclonal antibodyFeline
GM-Tg-cang-SE1351-Ab-1/ GM-Tg-cang-SE1351-Ab-2Anti-Canine TTC9B monoclonal antibodyCanine
GM-Tg-bovg-SE1351-Ab-1/ GM-Tg-bovg-SE1351-Ab-2Anti-Bovine TTC9B monoclonal antibodyBovine
GM-Tg-equg-SE1351-Ab-1/ GM-Tg-equg-SE1351-Ab-2Anti-Equine TTC9B monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE1351-Ab-1/ GM-Tg-hg-SE1351-Ab-2; GM-Tg-rg-SE1351-Ab-1/ GM-Tg-rg-SE1351-Ab-2;
GM-Tg-mg-SE1351-Ab-1/ GM-Tg-mg-SE1351-Ab-2; GM-Tg-cynog-SE1351-Ab-1/ GM-Tg-cynog-SE1351-Ab-2;
GM-Tg-felg-SE1351-Ab-1/ GM-Tg-felg-SE1351-Ab-2; GM-Tg-cang-SE1351-Ab-1/ GM-Tg-cang-SE1351-Ab-2;
GM-Tg-bovg-SE1351-Ab-1/ GM-Tg-bovg-SE1351-Ab-2; GM-Tg-equg-SE1351-Ab-1/ GM-Tg-equg-SE1351-Ab-2
Products NameAnti-TTC9B monoclonal antibody
Formatmab
Target NameTTC9B
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-TTC9B benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE1351-Ag-1Recombinant multi-species TTC9B protein


    Target information

    Target IDGM-SE1351
    Target NameTTC9B
    Gene ID148014,73032,361528,701620,100855596,101094556,100125944,100146308
    Gene Symbol and Synonyms2900074C18Rik,RGD1306256,TTC9B
    Uniprot AccessionQ8N6N2
    Uniprot Entry NameTTC9B_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000174521
    Target ClassificationN/A

    The target: TTC9B, gene name: TTC9B, also named as . 0.



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.